From *Rempex Pharmaceuticals, San Diego, California; †Institute for Clinical Pharmacodynamics, Latham, New York; and ‡JMI Laboratories, North Liberty, Iowa.
Accepted for publication June 21, 2013.
The authors have no funding or conflicts of interest to disclose.
Address for correspondence: Michael N. Dudley, PharmD, Rempex Pharmaceuticals, San Diego, CA 92121. E-mail: firstname.lastname@example.org.